Qiagen posts strong sales, earnings growth in Q1
May 4, 2021 -- Strong growth in both COVID-19 and non-COVID-19 product groups propelled Qiagen to a 48% increase in net sales at constant exchange rates in its first quarter. Read More
Labcorp to buy intellectual property from Myriad Genetics
May 3, 2021 -- Labcorp plans to buy some of Myriad Genetics' operating assets and intellectual property from its autoimmune business unit, including its Vectra rheumatoid arthritis assay. Read More
Thermo Fisher announces Q1 revenue increase
April 29, 2021 -- Thermo Fisher Scientific said that its efforts to help scale vaccine production and support diagnostic testing globally during the COVID-19 pandemic were partially responsible for significant revenue growth in its first quarter of 2021. Read More
Illumina donates $60M in NGS tools to build genomic network
April 28, 2021 -- Illumina is donating $60 million in next-generation sequencing (NGS) platforms, reagents, and support to create a comprehensive pathogen genomic network in South Asia. Read More
Venture capital funding for digital pathology tops $860M
April 27, 2021 -- While 2014-2017 reflected a relatively quiet period for investment in digital pathology, over the last three years there has been a significant uptick in funding, with a focus on artificial intelligence. Imogen Fitt of U.K. market insights firm Signify Research offers a perspective. Read More
SpeeDx secures European CE-IVD Mark for COVID-19 test
April 27, 2021 -- SpeeDx has received the European CE-IVD Mark for its PlexPCR test for SARS-CoV-2. The test targets two regions of the SARS-CoV-2 genome. Read More
FDA grants EUA for PathogenDx COVID-19 test
April 27, 2021 -- The U.S. Food and Drug Administration (FDA) has granted an emergency use authorization (EUA) to PathogenDx for the company's microarray-based COVID-19 test, DetectX-Rv. Read More
Boom in COVID testing drives Quidel's Q1 financials
April 23, 2021 -- Quidel on April 22 announced preliminary numbers for the first quarter of 2021 that saw revenue from the company's line of COVID-19 tests boom to $280 million compared to just $1 million in the second quarter of 2020. Read More
Group forms to evaluate early cancer detection tests
April 23, 2021 -- A group of more than 35 clinical researchers, academic institutions, healthcare provider organizations, patient advocacy groups, and private companies has formed to establish standards and guidance in multicancer early detection, an emerging field. Read More
Qiagen, DiaSorin debut Lyme disease assay
April 21, 2021 -- Qiagen and DiaSorin announced the launch of the Liaison LymeDetect assay for early detection of the Lyme Borreliosis infection. The test detects immunoglobulin G and immunoglobulin M antibodies and cellular immunity. Read More